Allen Investment Management LLC Exelixis, Inc. Transaction History

Allen Investment Management LLC

  • $8.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 06, 2018
SELL
$15.87 - $22.4 $207,563 - $292,969
-13,079 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$22.15 - $31.89 $2,968 - $4,273
134 Added 1.04%
13,079 $290,000
Q3 2017

Nov 07, 2017
BUY
$23.35 - $29.24 $302,265 - $378,511
12,945
12,945 $314,000

Others Institutions Holding EXEL

# of Institutions
502
Shares Held
243M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Allen Investment Management LLC Portfolio

Follow Allen Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email